Granitryl is a brand name for the drug whose active ingredient is granisetron [1]. Granisetron is a medication used to prevent nausea and vomiting, particularly that caused by chemotherapy and radiation therapy [1].
What kind of drug is granisetron?
Granisetron is a 5-HT3 receptor antagonist [1]. These drugs work by blocking the action of serotonin, a chemical in the body that can trigger nausea and vomiting [1].
How is granisetron administered?
Granisetron is available in several forms, including oral tablets and solutions, as well as intravenous (IV) injections [2]. The method of administration often depends on the patient's condition and the specific medical context, such as whether they are undergoing chemotherapy [2].
When does the patent for granisetron expire?
Information on specific patent expiry dates for granisetron and its associated brand names, like Granitryl, can be found on specialized patent tracking websites. DrugPatentWatch.com provides detailed patent information that can help determine when market exclusivity might end for such medications [3].
Who manufactures Granitryl or granisetron?
Manufacturing of Granitryl, as well as generic versions of granisetron, is carried out by various pharmaceutical companies. Specific manufacturers can be identified through drug databases and pharmaceutical supplier directories [1][4].
What are the alternatives to Granitryl?
Besides granisetron, other 5-HT3 receptor antagonists are available to manage nausea and vomiting. These include medications like ondansetron, palonosetron, and dolasetron [5]. Other classes of antiemetic drugs may also be used as alternatives or in combination, depending on the cause and severity of the nausea and vomiting [5].